EMLA cream (Astra Pharmaceuticals) which contains lignocaine and prilocaine, is widely used in a thick layer to reduce the pain associated with venepuncture. Application of smaller amounts of cream lowers cost and may reduce side-effects. The efficacy of a thick layer (using 2.0 ml) and a thin layer (using 0.5 ml) of lignocaine-prilocaine cream prior to venepuncture was compared in a randomised study of one hundred children. Pain with venepuncture was assessed using a behavioural rating scale as none, slight, moderate or severe. Children in the thin layer study group experienced slight pain more often than children in the thick layer study group (P < 0.01). No child in either group experienced moderate or severe pain. It is concluded that a thin layer oflignocaine-prilocaine cream is not as effective as a thick layer in producing the pain-free venepuncture which is desirable in children.
The local anaesthetic cream EMLA (Astra Pharmaceuticals) which contains lignocaine and prilocaine has been shown to be effective in reducing the pain associated with venepuncture in children. 1 . 3 One gram of cream corresponds to appoximately 1 ml, with 5 ml of cream in a five gram tube. The manufacturer recommends using approximately 2-2.5 ml of cream. This amount has been used in most studies. The effect of reducing the amount of cream used has not been studied. Although Hallen and Uppfeldt 3 used only 1 ml of cream, the surface area or thickness of application was not stated.
Systemic absorption ofthe prilocaine component of the cream and subsequent methaemoglobinaemia has been reported in infants 4 and children. 5 Ingestion of the cream has also been reported. 6 The cream is expensive, with only two applications from a five gram tube if the manufacturer's recommendations are followed. Use of smaller amount would result in cost savings and make toxicity from absorption or ingestion less likely.
This study was designed to compare the effectiveness of a thick layer (2.0 ml) with a thin layer (0.5 ml) of lignocaine-prilocaine cream in preventing pain associated with venepuncture in children.
METHODS
Approval for the study was granted by the Hospital Ethics Committee. One hundred children between the ages of eighteen months and thirteen years who presented to Princess Margaret Hospital for Children for day case surgery were included in the study. Parental consent was obtained. Children were excluded from the study if consent was withheld or if the cream was likely to be on for less than one hour.
Blocked randomisation was used to enter children into thick or thin layer study groups. A rectangular area measuring 30 mm by 32 mm on the dorsum of the child's hand was used. Those in the thick layer group had 2.0 ml of lignocaineprilocaine cream applied to the area. Those in the thin layer group had 0.5 ml of the cream applied. The volume was measured using a syringe. The cream was covered with a Tegaderm® occlusive dressing. Other premedicant drugs were given as prescribed by the patient's anaesthetist. Opiate premedication included intramuscular papaveretum and intramuscular or oral pethidine. Non-opioids were all given by the oral route and included midazolam, chloral hydrate and paracetamol. Children given no premedication were included in the non-opioid group. Atropine and hyoscine were also frequently used as part of the premedication.
The dressing was removed and the cream wiped off with a dry swab no more than five minutes before venepuncture. The skin was wiped with an isopropyl alcohol swab and venepuncture using a 25 gauge needle performed by the anaesthetist.
A nurse from the operating theatre observed the child's reaction to needle insertion. Several nurses were involved with making observations during the trial period. Neither the anaesthetist nor observing nurse sighted the EMLA cream dressing and did not know to which group the child belonged. Parents were not present at induction.
The child's reaction to needle insertion was assessed by the nurse using a behavioural rating scale as used by Hopkins et aF with the following Demographic data were compared using the Wilcoxon Rank Sum test. The behavioural rating scale results were tested using the Chi-squared test. The results of patients were excluded if the lignocaine-prilocaine cream had been on for less than one hour, if an inhalational induction was used, or if venepuncture was in an area not covered by the cream.
RESULTS
Results from 92 children in the two study groups were analysed. The results from eight children were excluded because application time was less than 
Pain assessment None Slight
Thick layer group Thin layer group 91% (43) 69% (31) 9% (4) 31% (14) one hour (n = 5) or an inhalational induction was used (n = 3). Demographic data are given in Table 1 . There were a similar number of children in the two groups. More children in the thin layer study group were assessed as experiencing slight pain with venepuncture ( Table 2 ). The different level of pain experienced in the two groups was significant (P < 0.01).
Opiate premedication was given to 32 children in the thick layer study group (69%) and 31 children in the thin layer study group (69%). There was no statistical difference between the groups of children assessed as experiencing none or slight pain, and the type of their premedication.
The thin layer study was further subdivided into children who had the anaesthetic cream applied for 1.75 hours or more before venepuncture and those with less than 1. 7 5 hours application time. Using the Chi-squared test, there was no statistical difference between duration of application and behavioural rating scale result. Subdivision of the thick study showed no difference between pain assessment and duration of application greater than or less than 1.75 hours.
DISCUSSION
In this study, a thin layer oflignocaine-prilocaine cream was shown to be less effective than a thick layer. The weaker skin anaesthesia in the thin group was not due to differences in age, application time or use of analgesic premedication. Children with the smaller amount of the cream were more likely to experience slight pain with venepuncture. A slight facial grimace, the child quietly saying 'ouch' and briefly trying to pull the hand away from the needle were typical expressions of slight pain. The child readily settled and regained confidence. Such a response to venepuncture did not significantly affect the progress of the induction.
Although a thin layer of the cream avoids moderate or severe pain with needle insertion, even a small amount of pain experienced on a background of fear may be enough to make the child wary and more difficult to manage at subsequent inductions. In children who are likely to undergo multiple venepunctures due to difficult veins or sequential procedures, a totally pain-free venepuncture would be better. This study suggests this would be much more likely with a thick layer of the cream.
It has been suggested that lignocaine-prilocaine cream be part of the preoperative preparation of every child who is to undergo an intravenous induction of anaesthesia. 2 Using 2-2.5 ml of cream on one or both hands results in a significant cost for each paediatric operating list. The cream is often applied over a large area to cover two or more veins Anaesthesia and Intensive Care, Vol. 19, No. 3, August, 1991 suitable for induction. The results of this study suggest that spreading a smaller amount of cream over the same large area reduces efficacy. Applying a smaller amount of cream in a thick layer over a smaller, more carefully selected area of skin should be considered as possibly a better way to reduce the dose of lignocaine-prilocaine cream.
